{"id":"https://openalex.org/W1529201210","doi":null,"title":"[Indications, contra-indications, expected results and choice of neoadjuvant chemotherapy for operable breast cancer].","display_name":"[Indications, contra-indications, expected results and choice of neoadjuvant chemotherapy for operable breast cancer].","publication_year":2006,"publication_date":"2006-11-01","ids":{"openalex":"https://openalex.org/W1529201210","mag":"1529201210","pmid":"https://pubmed.ncbi.nlm.nih.gov/17145582"},"language":"fr","primary_location":{"id":"pmid:17145582","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17145582","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bulletin du cancer","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069540694","display_name":"Marie\u2010Ange Mouret\u2010Reynier","orcid":"https://orcid.org/0000-0001-6981-1678","observed_orcids":["https://orcid.org/0000-0001-6981-1678","https://orcid.org/0000-0001-5542-5813"]},"institutions":[{"id":"https://openalex.org/I4210124119","display_name":"Centre Jean Perrin","ror":"https://ror.org/02pwnhd33","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210124119"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marie-Ange Mouret-Reynier","raw_affiliation_strings":["D\u00e9partement d'oncologie m\u00e9dicale et Unit\u00e9 de recherche clinique, Centre Jean-Perrin, Clermont-Ferrand. marie-ange.mouret-reynier@cjp.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement d'oncologie m\u00e9dicale et Unit\u00e9 de recherche clinique, Centre Jean-Perrin, Clermont-Ferrand. marie-ange.mouret-reynier@cjp.fr","institution_ids":["https://openalex.org/I4210124119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029086962","display_name":"Catherine Abrial","orcid":"https://orcid.org/0000-0002-1759-9457","observed_orcids":["https://orcid.org/0000-0002-1759-9457"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Catherine Abrial","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079006574","display_name":"Marianne Leheurteur","orcid":"https://orcid.org/0000-0002-1952-4790","observed_orcids":["https://orcid.org/0000-0002-1952-4790"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marianne Leheurteur","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030260555","display_name":"Xavier Durando","orcid":"https://orcid.org/0000-0001-6035-3172","observed_orcids":["https://orcid.org/0000-0001-6035-3172","https://orcid.org/0000-0001-7971-9808"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xavier Durando","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086724383","display_name":"Isabelle Van Praagh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Isabelle Van Praagh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064377722","display_name":"Pierre Gimbergues","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pierre Gimbergues","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113527248","display_name":"J.L. Achard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jean-Louis Achard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112235512","display_name":"Jean-Pierre Ferri\u00e8re","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jean-Pierre Ferri\u00e8re","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103548051","display_name":"Herv\u00e9 Cur\u00e9","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Herv\u00e9 Cure","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5072502548","display_name":"Philippe J. M. Chollet","orcid":"https://orcid.org/0000-0001-8457-7568","observed_orcids":["https://orcid.org/0000-0001-8457-7568"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philippe Chollet","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.07650317,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"93","issue":"11","first_page":"1121","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11134","display_name":"Breast Lesions and Carcinomas","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":1.0},{"id":"https://openalex.org/keywords/operable-breast-cancer","display_name":"operable breast cancer","score":0.9950000047683716},{"id":"https://openalex.org/keywords/locally-advanced-breast-cancer","display_name":"locally advanced breast cancer","score":0.8090000152587891},{"id":"https://openalex.org/keywords/inflammatory-breast-cancer","display_name":"inflammatory breast cancer","score":0.9210000038146973},{"id":"https://openalex.org/keywords/breast-conserving-surgery","display_name":"breast-conserving surgery","score":0.7689999938011169},{"id":"https://openalex.org/keywords/anthracyclines","display_name":"anthracyclines","score":0.8970000147819519},{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.996999979019165},{"id":"https://openalex.org/keywords/vinorelbine","display_name":"vinorelbine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/clinical-complete-response","display_name":"clinical complete response","score":0.7960000038146973},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.7210000157356262},{"id":"https://openalex.org/keywords/her2-overexpression","display_name":"HER2 overexpression","score":0.7580000162124634},{"id":"https://openalex.org/keywords/hormone-receptor-status","display_name":"hormone receptor status","score":0.7829999923706055},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.6890000104904175},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.32199999690055847},{"id":"https://openalex.org/keywords/local-recurrence","display_name":"local recurrence","score":0.531000018119812}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9287579655647278},{"id":"https://openalex.org/C2780350996","wikidata":"https://www.wikidata.org/wiki/Q420532","display_name":"Vinorelbine","level":4,"score":0.8116008043289185},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.697708249092102},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6873533725738525},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.590763509273529},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4986908435821533},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49640899896621704},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.4858207702636719},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45898425579071045},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.36802545189857483},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.2691357731819153}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000075202","descriptor_name":"Contraindications","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077235","descriptor_name":"Vinorelbine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020360","descriptor_name":"Neoadjuvant Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:17145582","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17145582","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bulletin du cancer","raw_type":"Journal Article"},{"id":"mag:1529201210","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17145582","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2003311516","https://openalex.org/W2008792450","https://openalex.org/W1255356622","https://openalex.org/W1975231908","https://openalex.org/W1981229614","https://openalex.org/W2034883192","https://openalex.org/W199834675","https://openalex.org/W2090099783","https://openalex.org/W1961616138","https://openalex.org/W2256609014"],"abstract_inverted_index":{"Neoadjuvant":[0],"chemotherapy":[1,35,102,217],"in":[2,21,39,55,58,71,79,92,111,260],"breast":[3,32,112,172],"cancer":[4,113,173],"corresponds":[5],"to":[6,60,121,144,149,205,227,248,265],"the":[7,22,27,40,74,80,95,98,106,141,164,169,194,220,223,267],"use":[8,195],"of":[9,26,42,73,82,94,97,108,159,171,174,196,222,254],"a":[10,62,136,182,186,202,215],"systemic":[11],"treatment":[12,16,25,170],"applied":[13],"before":[14],"loco-regional":[15,99],"(surgery":[17],"and/or":[18,30,54],"radiotherapy).":[19],"Initiated":[20],"seventies":[23],"for":[24,44,168],"locally":[28],"advanced":[29],"inflammatory":[31],"cancers,":[33],"induction":[34],"has":[36],"been":[37],"extended":[38],"beginning":[41],"eighties":[43],"cancers":[45],"known":[46],"as":[47,233],"operable":[48],"(size":[49],"higher":[50],"than":[51],"3":[52],"cm":[53],"central":[56],"position)":[57],"order":[59],"allow":[61],"more":[63,211],"frequent":[64],"conservating":[65],"surgery.":[66],"This":[67,241],"objective":[68],"is":[69,140,218],"obtained":[70],"75%":[72],"cases":[75],"approximately":[76],"without":[77,86],"increase":[78],"risk":[81],"local":[83],"relapse":[84],"and":[85,118,178,208,238],"noxious":[87],"effect":[88],"on":[89],"overall":[90],"survival,":[91],"spite":[93],"delay":[96],"treatment.":[100],"Neo-adjuvant":[101],"progressively":[103],"moved":[104],"with":[105,201,246],"advent":[107],"major":[109,166],"drugs":[110,167],"which":[114,175],"are":[115,176],"anthracyclins,":[116],"vinorelbine":[117],"taxans.":[119],"But":[120],"date,":[122],"no":[123],"protocol":[124],"was":[125],"essential":[126],"like":[127,199],"an":[128],"uncontested":[129],"standard.":[130],"However,":[131],"it":[132],"seems":[133,148,204],"that":[134],"obtaining":[135],"complete":[137],"clinical":[138],"response":[139,250],"best":[142],"guarantor":[143],"avoid":[145],"relapse.":[146],"That":[147],"be":[150,206,210],"observed":[151],"only":[152],"after":[153,185],"6":[154],"cycles,":[155],"even":[156],"8":[157],"cycles":[158],"chemotherapy,":[160,203],"each":[161],"cycle":[162],"combining":[163],"2":[165],"anthracyclins":[177],"taxanes":[179],"employed":[180],"according":[181],"sequential":[183],"scheme":[184],"based-anthracyclins":[187],"treatment,":[188],"except":[189],"any":[190],"cardiac":[191],"contra-indication.":[192],"Moreover,":[193],"targeted":[197],"therapeuticals":[198],"Herceptin,":[200],"promising":[207],"should":[209],"studied.":[212],"Finally,":[213],"when":[214],"neoadjuvant":[216],"administered,":[219],"evaluation":[221,242],"pre-treatment":[224],"biopsy":[225],"helps":[226],"establish":[228],"key":[229],"patient-management":[230],"parameters":[231,245],"such":[232],"tumour":[234],"type,":[235],"SBR":[236],"grade":[237],"immunohistochemical":[239],"parameters.":[240],"provides":[243],"predictive":[244],"regards":[247],"drug":[249],"(hormonal":[251],"status,":[252],"overexpression":[253],"Her2).":[255],"The":[256],"further":[257],"studies":[258],"realised":[259],"this":[261],"way":[262],"will":[263],"permit":[264],"improve":[266],"results":[268],"yet":[269],"obtained.":[270]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}